|
|
|
|
EM Jancis, R Carbone, KJ Loechner and PS Dannies
Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06510.
Rhodamine 123 is a fluorescent dye that localizes in mitochondria, is a substrate for the multidrug resistance pump, and is retained for long periods of time by carcinoma cells. 17 beta-Estradiol causes GH4C1 cells (rat pituitary tumor cells) to lose rhodamine 123 fluorescence faster than untreated cells. We found that estradiol induces accumulation of the mRNA for the multidrug resistance pump 3-5-fold, with maximum induction occurring within 1 day at 10(-9) M estradiol. Immunoblot analysis demonstrated that estradiol induces a protein of 150 kDa that reacts with an antibody to P-glycoprotein, the multidrug resistance pump. The reduced retention of rhodamine 123 caused by estradiol is prevented by verapamil and cyclosporin, inhibitors of the pump. A clone resistant to the effects of estradiol on rhodamine 123 has greatly reduced levels of mRNA for the pump. The effect of estradiol is more marked on rhodamine 123 retention than it is on that of rhodamine 110 or tetramethylrhodamine methyl ester. We conclude that estradiol enhances rhodamine 123 efflux by inducing the multidrug resistance gene. The specificity for rhodamine 123, compared with other analogs, may be caused by differences in accessibility to the pump.
This article has been cited by other articles:
![]() |
E. V. Batrakova, S. Li, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov Optimal Structure Requirements for Pluronic Block Copolymers in Modifying P-glycoprotein Drug Efflux Transporter Activity in Bovine Brain Microvessel Endothelial Cells J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 845 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Batrakova, S. Li, S. V. Vinogradov, V. Y. Alakhov, D. W. Miller, and A. V. Kabanov Mechanism of Pluronic Effect on P-Glycoprotein Efflux System in Blood-Brain Barrier: Contributions of Energy Depletion and Membrane Fluidization J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 483 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bontenbal, W. L. J. van Putten, J. Th. M. Burghouts, M. G. A. Baggen, G. J. Ras, W. F. Stiegelis, M. Beudeker, J. Th. P. Janssen, J. J. Braun, G. H. M. van der Linden, et al. Value of Estrogenic Recruitment Before Chemotherapy: First Randomized Trial in Primary Breast Cancer J. Clin. Oncol., February 14, 2000; 18(4): 734 - 734. [Abstract] [Full Text] [PDF] |
||||